Table 1 Baseline clinical characteristics according to the statin use adherence at six months after discharge
Baseline variables | Good adherence | Poor adherence | P-value |
|---|---|---|---|
(n = 9019) | (n = 3497) | ||
Studies, n(%) | |||
CPACS-1 | 1415(15.7) | 512(14.6) | 0.145 |
CPACS-2 | 7604(84.3) | 2985(85.4) | |
Male, n(%) | 6380(70.7) | 2390(68.3) | 0.009 |
Age,mean(SD) | 63.33(11.5) | 63.34(11.8) | 0.974 |
High School or higher, n(%) | 3444(38.2) | 1252(35.8) | 0.013 |
Occupations, n(%) | |||
Employed | 4605(51.1) | 1767(50.5) | 0.844 |
Not-employed | 4214(46.7) | 1654(47.3) | |
Unknown | 200(2.2) | 76(2.2) | |
Tertiary hospital, n(%) | 5781(64.1) | 1987(56.8) | <0.001 |
Having health insurance, n(%) | 7308(81.0) | 2700(77.2) | <0.001 |
Smoking, n(%) | 2748(30.5) | 1096(31.3) | 0.343 |
Subtype of ACS, n(%) | |||
STEMI | 3530(39.1) | 1347(38.5) | 0.104 |
Non-STEMI | 1206(13.4) | 427(12.2) | |
Unstable angina | 4283(47.5) | 1723(49.3) | |
CVD risk factors, n(%) | |||
Hypertension | 6354(70.5) | 2402(68.7) | 0.053 |
Diabetes Mellitus | 1892(21.0) | 655(18.7) | 0.005 |
Dyslipidemia* | 4807(53.3) | 1734(49.6) | <0.001 |
Smoking | 2748(30.5) | 1096(31.3) | 0.343 |
Obesity | 897(10.0) | 321(9.2) | 0.194 |
Family history of early CHD, n(%) | 414(4.6) | 171(4.9) | 0.476 |
Higher heart rate(> = 100/min),n(%) | 657(7.3) | 277(7.9) | 0.224 |
Continuous ECG monitoring, n(%) | 6487(71.9) | 2436(69.7) | 0.012 |
Treatments during hospitalization, n(%) | |||
PCI/CABG | 4746(52.6) | 1334(38.2) | <0.001 |
Thrombolysis | 608(6.7) | 318(9.1) | <0.001 |
Statin before hospitalization | 1681(18.6) | 513(14.7) | <0.001 |
PCI/CABG in 0–6 months, n(%) | 308(3.4) | 131(3.8) | 0.3663 |
Adherence of other medications in 0–6 months, n(%) | |||
Aspirin | 8573(95.1) | 2742(78.4) | <0.001 |
Clopidogrel | 5962(66.1) | 1414(40.4) | <0.001 |
Beta-blocker | 6602(73.2) | 1772(50.7) | <0.001 |
Angiotensin-converting enzyme inhibitor/Angiotensin receptor blocker | 6312(70.0) | 1493(42.7) | <0.001 |